Event Registration
Last Chance Seminar Jackson
12/10/2019 06:00 PM - 08:00 PM CT
Admission
- $49.00 - Member Pricing
- $199.00 - Non-Member Pricing
Location
UM School of Pharmacy
2500 North State Street
Jackson, MS 39216
Room Number: Auditorium
2500 North State Street
Jackson, MS 39216
Room Number: Auditorium
Summary
MPhA Member Price- $49.00
Non-Member Price- $199.00 This includes 2 hours of CE and a 2020 membership to MPhA.
This seminar will provide two (2) hours of live opioid/drugs of abuse CE credits required by the Board of Pharmacy. This will be the last live CE opportunity provided by MPhA for 2019.
“Vaping and Juuling: Essential Information for E-Cigs and How Juul Changed the Game”
Presented by: Dave Weldon, PhD
Objectives for Vaping CE:
This Vaping Continuing Education session is designed to:
1. Describe the mechanics and devices of vaping.
2. Describe the initial youth marketing campaigns of vaping companies.
3. Compare the common flavoring constituents and known health risks of vaping fluids.
4. Describe the use of vaping as a cigarette cessation/risk reduction strategy by the government of the United Kingdom.
5. Summarize the clinical trials of vaping to date.
6. Report on the acute and chronic lung injuries related to the use of vaping products.
Event Registration is closed.
Non-Member Price- $199.00 This includes 2 hours of CE and a 2020 membership to MPhA.
This seminar will provide two (2) hours of live opioid/drugs of abuse CE credits required by the Board of Pharmacy. This will be the last live CE opportunity provided by MPhA for 2019.
“Vaping and Juuling: Essential Information for E-Cigs and How Juul Changed the Game”
Presented by: Dave Weldon, PhD
Objectives for Vaping CE:
This Vaping Continuing Education session is designed to:
1. Describe the mechanics and devices of vaping.
2. Describe the initial youth marketing campaigns of vaping companies.
3. Compare the common flavoring constituents and known health risks of vaping fluids.
4. Describe the use of vaping as a cigarette cessation/risk reduction strategy by the government of the United Kingdom.
5. Summarize the clinical trials of vaping to date.
6. Report on the acute and chronic lung injuries related to the use of vaping products.